Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Clinical trial NCT05804370 · RECRUITING
Trial details
- NCT number
- NCT05804370
- Sponsor
- NX Development Corp
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2028-09-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.